SciSparc (SPRC) Stock Price, News & Analysis

Company Overview

SciSparc Ltd. (NASDAQ: SPRC) is an Israel-based specialty pharmaceutical company focused on developing therapies for disorders of the central nervous system. The company’s research is centered on cannabinoid-based pharmaceutical compositions and combinations intended to address conditions with limited treatment options.

SciSparc’s development pipeline has included SCI-110, an investigational cannabinoid-based treatment being studied for Tourette syndrome and obstructive sleep apnea, as well as SCI-210, a combination therapy under development for autism spectrum disorder. The company has also pursued SCI-160, an investigational therapy for pain management. These candidates remain subject to clinical testing and regulatory review.

The company was previously known as Therapix Biosciences Ltd. and adopted the SciSparc name as it expanded its focus on cannabinoid-based therapies. Its operations and research activities are based primarily in Israel, with clinical and development work conducted through external research institutions and collaborators as applicable.

Key Stats

• Today's Range: $3.89 to $4.17
• 50-Day Range: $3.94 to $6.93
• 52-Week Range: $2.98 to $43.65
• Volume: 22,054 shs
• Average Volume: 19,719 shs
• Market Capitalization: $2.25 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

SciSparc Stock Analysis - MarketRank™

SciSparc scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

SciSparc has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

SciSparc has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

SciSparc has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.04% of the float of SciSparc has been sold short.

Short Interest Ratio / Days to Cover

SciSparc has a short interest ratio ("days to cover") of 0.44, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in SciSparc has recently increased by 3.54%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SciSparc does not currently pay a dividend.

Dividend Growth

SciSparc does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.96

News Sentiment

SciSparc has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 7 news articles for SciSparc this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for SPRC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SciSparc insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.52% of the stock of SciSparc is held by insiders.

Percentage Held by Institutions

25.06% of the stock of SciSparc is held by institutions.

Company Calendar

• Last Earnings: 8/14/2026
• Today: 10/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:SPRC
• CIK: 1611746
• Web: scisparc.com
• Phone: 972-3717-5777
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.87
• Quick Ratio: 0.86

Sales & Book Value

• Annual Sales: $860 thousand
• Price / Sales: 2.61
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $12.93 per share
• Price / Book: 0.30

Miscellaneous

• Outstanding Shares: 570,000
• Free Float: 557,000
• Market Cap: $2.25 million
• Optionable: Not Optionable
• Beta: 2.83